Voyager Therapeutics (VYGR)
Develops CNS gene therapies and antibodies around TRACER delivery and tau biology.
$2.97
vs last close−0.18 (−5.57%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 47 days
EPS estimate
−$0.41
Revenue estimate
$6.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.59−$0.53−$0.57−$0.47−$0.46−$0.47−$0.40Pending
Estimate−$0.35−$0.35−$0.48−$0.53−$0.54−$0.54−$0.48−$0.41
Surprise−68.6%−51.4%−18.7%+11.3%+14.8%+13.0%+17.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$6.3M$6.5M$5.2M$13.4M$15.3M$2.6M$3.2MPending
Estimate$12.9M$13.9M$7.9M$10.5M$10.5M$8.8M$4.5M$6.3M
Surprise−51.5%−53.5%−33.8%+27.4%+46.2%−70.5%−30.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.42 | — | — |
| Sep 2027 | −$0.37 | — | — |
| Jun 2027 | −$0.37 | — | — |
| Mar 2027 | −$0.45 | — | — |
| Dec 2026 | −$0.40 | — | — |
| Nov 2026 | −$0.41 | — | — |
| Aug 2026 | −$0.48 | −$0.40 | +17.3% |
| May 2026 | −$0.54 | −$0.47 | +13.0% |
| Mar 2026 | −$0.54 | −$0.46 | +14.8% |
| Nov 2025 | −$0.53 | −$0.47 | +11.3% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Nov 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.42 | — | — | $5.7M | — | — | — |
| Sep 2027 | −$0.37 | — | — | $7.9M | — | — | — |
| Jun 2027 | −$0.37 | — | — | $5.4M | — | — | — |
| Mar 2027 | −$0.45 | — | — | $10.3M | — | — | — |
| Dec 2026 | −$0.40 | — | — | $8.1M | — | — | — |
| Nov 9, 2026 | −$0.41 | — | — | $6.3M | — | — | — |
| Aug 6, 2026 | −$0.48 | −$0.40 | +17.3% | $4.5M | $3.2M | −30.0% | +4.5% |
| May 7, 2026 | −$0.54 | −$0.47 | +13.0% | $8.8M | $2.6M | −70.5% | −5.0% |
| Mar 9, 2026 | −$0.54 | −$0.46 | +14.8% | $10.5M | $15.3M | +46.2% | +5.4% |
| Nov 10, 2025 | −$0.53 | −$0.47 | +11.3% | $10.5M | $13.4M | +27.4% | +0.7% |
| Aug 6, 2025 | |||||||
| May 6, 2025 | |||||||
| Mar 11, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 13, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 7, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 4, 2022 | |||||||
| Mar 8, 2022 | |||||||
| Nov 2, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 6, 2020 | |||||||
| Mar 3, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 26, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 14, 2018 | |||||||
| Nov 2, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 15, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 11, 2016 | |||||||
| May 12, 2016 | |||||||
| Mar 17, 2016 | |||||||
| Dec 17, 2015 | |||||||
| Nov 16, 2015 |